Share price plungingBack on November 18th there was a news release saying the company is preparing for commercial production of API-grade Psilocybin with intial production starting in Jan/23. We have heard nothing more about this. Maybe they are holding back news so the stock falls so they can do a cheap PP and piece in some their friends at low share prices. Or it could be there are simply no revenues and no good news to report.